Coinciding with the FDA’s clearance for the catheter, Perfuze has also completed a €22m ($24m) financing round.

Perfuze, an Ireland-based developer of catheter-based aspiration technology for the treatment of acute ischemic stroke, ...

Perfuze, a leading medical device company dedicated to advancing stroke treatment, today announced that it has received FDA ...

Penumbra's thrombectomy growth and new products show promise, but high valuation at 7x 2025 revenue tempers appeal for GARP ...

Computer vision artificial intelligence can improve patient care, but reaping its full benefits relies on careful training, ...

Nature is the vast eternal kingdom which nourishes art,” Munch observed, and this vast source was not a choice but a ...

Early surgical or transcatheter aortic valve replacement is not typically recommended for severe aortic stenosis in the ...

Grey's Anatomy has produced some of the best relationships of all time over the last two decades, and these are the best ...

Medtronic has announced the SMART trial’s two-year outcomes of Evolut TAVR for aortic stenosis (AS) and small aortic annulus.

The CaRi-Plaque technology supports non-invasive analysis of coronary anatomy and pathology from routine coronary computed ...